Investing.com - Alpha Tau Medical reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Alpha Tau Medical announced earnings per share of $-0.040 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.116 on revenue of $0.00.
Alpha Tau Medical 's are down 61% and is trading at $3.750 , still down 81.84% from its 52 week high of $20.65 set on Thursday, March 24, 2022.
Alpha Tau Medical follows other major Healthcare sector earnings this month
Alpha Tau Medical's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, EPS of $1.91 on revenue of $6.91B.
AbbVie had beat expectations on Friday, October 28, 2022 with third quarter EPS of $3.66 on revenue of $14.81B, for EPS of $3.58 on revenue of $14.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar